(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ZIANA (CLINDAMYCIN PHOSPHATE 1.2% AND TRETINOIN 0.025%) GEL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

ZIANA (CLINDAMYCIN PHOSPHATE 1.2% AND TRETINOIN 0.025%) GEL

ST13

US500000077055122

Class

5

Filing

77055122

Registration

3319298

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

60

Latest update

02/19/2026

Classification

Registered

Trademark type

Combined

Nice classes

5

Filing date

12/01/2006

Registration date

10/23/2007

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/05/2017

Last transaction

02/19/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

12/19/2006

First use in commerce

12/19/2006

Drawing code

3

Owner type

03

Owner location

Bridgewater, NJ

Examiner

BIBB, SCOTT

Law office

L90

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

M. C. (pessoa física)
M. C. (pessoa física)

Representatives

Jeremy Blackowicz Bausch Health Companies

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

pharmaceutical preparations for dermatologic usetopical preparations for the treatment of acne and topical preparations for the treatment of steroid-responsive dermatosesexcluding preparations for the treatmentalleviation of viral infectionsregardless of their dosage form

Publications

History of USPTO decisions and trademark events.

60 publications found

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

02/18/2026

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

02/11/2026

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

05/14/2025

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

05/07/2025

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

04/16/2025

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

12/28/2022

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

12/14/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/22/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/22/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/22/2022

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

06/23/2022

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

03/09/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

10/16/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/16/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/16/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/16/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

10/16/2021

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

11/25/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

09/08/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/08/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/08/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/08/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

09/08/2020

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

10/05/2017

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

10/05/2017

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

10/05/2017

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/05/2017

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/01/2017

E89R

TEAS SECTION 8 & 9 RECEIVED

09/01/2017

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

10/23/2016

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

01/21/2015

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

10/21/2013

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

10/21/2013

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/21/2013

815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

10/10/2013

E815

TEAS SECTION 8 & 15 RECEIVED

10/10/2013

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/10/2013

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

05/01/2013

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/12/2009

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/12/2009

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/08/2008

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/08/2008

R.PR

REGISTERED-PRINCIPAL REGISTER

10/23/2007

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

09/14/2007

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

09/11/2007

SUPC

STATEMENT OF USE PROCESSING COMPLETE

09/07/2007

IUAF

USE AMENDMENT FILED

08/20/2007

EISU

TEAS STATEMENT OF USE RECEIVED

08/20/2007

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

07/24/2007

PUBO

PUBLISHED FOR OPPOSITION

05/01/2007

NPUB

NOTICE OF PUBLICATION

04/11/2007

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

03/06/2007

ALIE

ASSIGNED TO LIE

03/06/2007

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/01/2007

XAEC

EXAMINER'S AMENDMENT ENTERED

01/30/2007

GNEA

EXAMINERS AMENDMENT E-MAILED

01/30/2007

CNEA

EXAMINERS AMENDMENT -WRITTEN

01/30/2007

DOCK

ASSIGNED TO EXAMINER

01/29/2007

MDSC

NOTICE OF DESIGN SEARCH CODE MAILED

12/06/2006

NWAP

NEW APPLICATION ENTERED

12/05/2006

Continuous trademark protection

Get notified about every new filing that threatens ZIANA (CLINDAMYCIN PHOSPHATE 1.2% AND TRETINOIN 0.025%) GEL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.